open access
COVID-19 on board a cruise ship: medical management
- Société Française de Médecine Maritime, Brest, France
- Medical staff of Ponant Company 408, Marseille, France
- Service de santé des gens de mer, Brest, France
- Université de Bretagne Occidentale; Centre Régional de Pathologies Professionnelles et Environnementales, Brest, France
open access
Abstract
Background: First, this analysis was conducted to study a coronavirus disease 2019 (COVID-19) cluster
dynamic on a cruise ship in order to allow the ship physician to anticipate the duration and importance
of the contaminations. Secondly, the author tries to find out if the closed environment on board allows
specific conclusions about epidemic dynamics and preventative measures.
Materials and methods: From a personal epidemiological compendium done by himself on board the author
analysed different epidemic curves identified on board other ships and compared them to the epidemiologic
data from the different COVID-19 contamination waves in France since 2020. All crew members
were submitted to polymerase chain reaction tests on D2, D5, D8 and D15 and symptomatic cases were
tested on on-board devices in the meantime. An excel file called “Log Covid” allowed for daily reporting
to the ship-owner on the epidemic dynamics and the prospects on the end of crises in order to anticipate
the resumption of the business in the best conditions. The jobs on board, age and geographic origin
of the contaminated people were analysed, as well as their vaccination status.
Results: Out of a total of 118 crew members, 61 (52%) sailors were contaminated in 8 days. The symptoms
were benign (pharyngitis, headaches, feverish state); no serious form of illness were reported. The passengers
were repatriated to France at the earliest stage. The epidemic phase occurred in a 15-day window.
The first 8 days corresponded to the ascending phase, then a faster phase of epidemic decrease of 7 days.
Similarities emerged between the epidemic dynamics of this virus and other contaminations on cruise
ships and epidemic phases on land in spite of important differences in numbers.
Conclusions: This study can allow a ship’s doctor to better understand the viral dynamics in case of a COVID-
19 cluster and to anticipate the exit of the crisis. Repeated tests during the active phase of the epidemic
are necessary in case of a large cluster to know where to place oneself on a typical epidemic curve. Isolation
and barrier measures advised by the ship’s doctor remain the only weapons that can limit its magnitude.
Abstract
Background: First, this analysis was conducted to study a coronavirus disease 2019 (COVID-19) cluster
dynamic on a cruise ship in order to allow the ship physician to anticipate the duration and importance
of the contaminations. Secondly, the author tries to find out if the closed environment on board allows
specific conclusions about epidemic dynamics and preventative measures.
Materials and methods: From a personal epidemiological compendium done by himself on board the author
analysed different epidemic curves identified on board other ships and compared them to the epidemiologic
data from the different COVID-19 contamination waves in France since 2020. All crew members
were submitted to polymerase chain reaction tests on D2, D5, D8 and D15 and symptomatic cases were
tested on on-board devices in the meantime. An excel file called “Log Covid” allowed for daily reporting
to the ship-owner on the epidemic dynamics and the prospects on the end of crises in order to anticipate
the resumption of the business in the best conditions. The jobs on board, age and geographic origin
of the contaminated people were analysed, as well as their vaccination status.
Results: Out of a total of 118 crew members, 61 (52%) sailors were contaminated in 8 days. The symptoms
were benign (pharyngitis, headaches, feverish state); no serious form of illness were reported. The passengers
were repatriated to France at the earliest stage. The epidemic phase occurred in a 15-day window.
The first 8 days corresponded to the ascending phase, then a faster phase of epidemic decrease of 7 days.
Similarities emerged between the epidemic dynamics of this virus and other contaminations on cruise
ships and epidemic phases on land in spite of important differences in numbers.
Conclusions: This study can allow a ship’s doctor to better understand the viral dynamics in case of a COVID-
19 cluster and to anticipate the exit of the crisis. Repeated tests during the active phase of the epidemic
are necessary in case of a large cluster to know where to place oneself on a typical epidemic curve. Isolation
and barrier measures advised by the ship’s doctor remain the only weapons that can limit its magnitude.
Keywords
COVID-19, infection, maritime, boat
Title
COVID-19 on board a cruise ship: medical management
Journal
Issue
Article type
Original article
Pages
83-88
Published online
2023-06-30
Page views
1331
Article views/downloads
425
DOI
Pubmed
Bibliographic record
IMH 2023;74(2):83-88.
Keywords
COVID-19
infection
maritime
boat
Authors
Laurent Beust
David Lucas
Richard Pougnet
Brice Loddé
- Kordsmeyer AC, Mojtahedzadeh N, Heidrich J, et al. Systematic review on outbreaks of SARS-COV-2 on cruise, navy and cargo ships. Int J Environ Res Public Health. 2021; 18(10): 5195.
- Rosca E, Heneghan C, Spencer E, et al. Transmission of SARS-COV-2 associated with cruise ship travel: a systematic review. Trop Med Infectious Disease. 2022; 7(10): 290.
- Codreanu TA, Ngeh S, Trewin A, et al. Successful control of an onboard COVID-19 outbreak using the cruise ship as a quarantine facility, Western Australia, Australia. Emerg Infect Dis. 2021; 27(5): 1279–1287.
- Chatard JC, Le Gac JM, Gonzalo S, et al. Management of COVID-19 on board the mixed cargo ship Aranui 5. Int Marit Health. 2021; 72(3): 155–162.
- Jimi H, Hashimoto G. Challenges of COVID-19 outbreak on the cruise ship Diamond Princess docked at Yokohama, Japan: a real-world story. Glob Health Med. 2020; 2(2): 63–65.
- Baraniuk C. What the Diamond Princess taught the world about COVID-19. BMJ. 2020; 369: m1632.
- Jégaden D, Dewitte JD, Loddé B. Maritime medicine in France. Int Marit Health. 2004; 55(1-4): 131–136.
- Ogden N, Fazil A, Arino J, et al. Scénarios de modélisation de l’épidémie de COVID-19 au Canada. Relevé des maladies transmissibles au Canada. 2020: 225–231.
- Davis JT, Chinazzi M, Perra N, et al. Cryptic transmission of SARS-CoV-2 and the first COVID-19 wave. Nature. 2021; 600(7887): 127–132.
- Zhang Hu, Wang Q, Chen J, et al. Cruise tourism in the context of COVID-19: Dilemmas and solutions. Ocean Coast Manag. 2022; 228: 106321.